These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3700681)

  • 21. Drug therapy in childhood: what has been done and what has to be done?
    Bartels H
    Pediatr Pharmacol (New York); 1983; 3(3-4):131-43. PubMed ID: 6677868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthy volunteers for bioequivalence trials: predictive factors for enrollment failures--a case-control study.
    Yerino GA; Halabe EK; Feleder EC
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):231-6. PubMed ID: 21329625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical trials of drugs without immediate therapeutic objectives].
    Cheymol G
    Ann Med Interne (Paris); 1987; 138(3):173-7. PubMed ID: 3619247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paediatric pharmacokinetics: key considerations.
    Batchelor HK; Marriott JF
    Br J Clin Pharmacol; 2015 Mar; 79(3):395-404. PubMed ID: 25855821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Representation of American blacks in clinical trials of new drugs.
    Svensson CK
    JAMA; 1989 Jan; 261(2):263-5. PubMed ID: 2909024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
    Shah RR
    Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.
    Hartmanshenn C; Scherholz M; Androulakis IP
    J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):481-504. PubMed ID: 27647273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Criteria supporting the study of drugs in the newborn.
    Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A
    Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism and pharmacokinetics in children and the elderly.
    Pelkonen O
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):147-8. PubMed ID: 17428146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethical concerns about research on incompetent persons.
    Lynn J
    J Am Geriatr Soc; 1998 May; 46(5):660. PubMed ID: 9588388
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations.
    Kauffman RE; Kearns GL
    Clin Pharmacokinet; 1992 Jul; 23(1):10-29. PubMed ID: 1617856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetic registration file for NDA and ANDA procedures.
    Marzo A
    Pharmacol Res; 1997 Dec; 36(6):425-50. PubMed ID: 9446710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psycho- and immunopharmacological factors relevant to selection of volunteers in clinical studies.
    Meyer FP
    Int J Clin Pharmacol Ther; 2001 Jul; 39(7):300-10. PubMed ID: 11471774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human volunteer studies with non-pharmaceutical chemicals: metabolism and pharmacokinetic studies.
    Wilks MF; Woollen BH
    Hum Exp Toxicol; 1994 Jun; 13(6):383-92. PubMed ID: 8086220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current issues surrounding women and minorities in drug trials.
    Wermeling DP; Selwitz AS
    Ann Pharmacother; 1993; 27(7-8):904-11. PubMed ID: 8364277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug response in the elderly--sensitivity and pharmacokinetic considerations.
    Crooks J; Stevenson IH
    Age Ageing; 1981 May; 10(2):73-80. PubMed ID: 7246339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of healthy volunteers for phase I studies.
    Sibille M
    Fundam Clin Pharmacol; 1990; 4 Suppl 2():167s-176s. PubMed ID: 2093628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethical problems in the use of controls in medical research.
    Hay P
    N Z Med J; 1988 Sep; 101(854):608-10. PubMed ID: 3173856
    [No Abstract]   [Full Text] [Related]  

  • 40. Sex-related differences in drug disposition in man.
    Wilson K
    Clin Pharmacokinet; 1984; 9(3):189-202. PubMed ID: 6375930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.